SPAC Healthcare Capital Secures Shareholder Approval Of US$1 Billion SPAC Merger

Special purpose acquisition company Healthcare Capital Corp. (Nasdaq: HCCC) announced today that it has secured its shareholders’ approval of the proposed business combination with Israeli medical device company Alpha Tau Medical. The transaction values the combined company at a pro forma equity value of US$1 billion, assuming no redemptions take place.

The combined company, expected to operate under Alpha Tau, plans to trade on the Nasdaq under the symbol “DRTS” and “DRTSW” for its shares and warrants, respectively.

With 65.64% of shareholders on record, around 94.57% voted for the proposed merger.

Post-transaction, Alpha Tau shareholders will own 59.3% of the combined firm.

The blank check firm closed its US$275 million IPO in January 2021. According to its prospectus, it intended to pursue a business combination within the healthcare industry.

The Israeli firm focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors.

Healthcare Capital last traded at US$10.08 on the Nasdaq.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver @ $36 & We’re Still 200M Oz Short | Paul Andre Huet – Americas Gold and Silver

Gold’s Wild Bull Run: Are Markets About to Break? | Mike McGlone

First Majestic Silver: The Santa Elena Mine

Recommended

Goliath Resources Closes Out Funding Round With Total Gross Proceeds Of $27.1 Million

Silver47 Kickstarts 4,000 Metre Drill Campaign At Red Mountain Project

Related News

Clean Transition SPAC Monterey Capital Acquisition Prices Downsized US$80 Million IPO

Special purpose acquisition company Monterey Capital Acquisition Corporation (Nasdaq: MCACU) started trading its securities on...

Wednesday, May 11, 2022, 02:19:00 PM

Asia-Focused Biotech SPAC Valuence Merger I Prices US$200 Million IPO

Special purpose acquisition company Valuence Merger Corp. I (Nasdaq: VMCAU) started trading on the Nasdaq...

Tuesday, March 1, 2022, 02:26:00 PM

SPAC Alberton Acquisition Faces Nasdaq Suspension After Last Proposed Merger Failed

Special purpose acquisition company Alberton Acquisition Corp. (Nasdaq: ALAC) announced that its proposed merger with...

Monday, April 25, 2022, 02:24:00 PM

Health SPAC CHW Acquisition Upsizes IPO To US$110 Million

Special purpose acquisition company CHW Acquisition Corporation (Nasdaq: CHWAU) went public on the Nasdaq Capital...

Wednesday, September 1, 2021, 11:19:00 AM

Energy SPAC Energem Seeks To Raise US$100 Million In IPO

Special purpose acquisition company Energem Corp. (Nasdaq: ENCPU) went public on the Nasdaq Global Market...

Tuesday, November 16, 2021, 02:10:00 PM